Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

9

Number of overlapping holdings

13.8%

% of XLV's 65 holdings also in XPH

24.3%

% of XPH's 40 holdings also in XLV

Overlap by Weight
Sector Drift (XLV minus XPH)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in XLV
Weight
in XPH
Overlap
ELI LILLY & CO 9.2% 5.6% 5.6%
MERCK & CO. INC. 5.5% 4.2% 4.2%
JOHNSON & JOHNSON 7.9% 4.0% 4.0%
PFIZER INC 3.9% 3.8% 3.8%
BRISTOL-MYERS SQUIBB CO 2.5% 3.9% 2.5%

Position Highlights (Non-Overlapping Exposures)
XLV Overweight Relative to XPH
UNITEDHEALTH GROUP INC 9.2%
ABBVIE INC 5.4%
THERMO FISHER SCIENTIFIC INC 4.0%
JOHNSON & JOHNSON 3.9%
ELI LILLY & CO 3.6%
ABBOTT LABORATORIES 3.6%
DANAHER CORP 3.4%
AMGEN INC 2.8%
MEDTRONIC PLC 2.2%
ANTHEM INC 2.1%
XLV Underweight Relative to XPH
REATA PHARMACEUTICALS, INC. CLASS A -7.9%
ELANCO ANIMAL HEALTH, INC. -5.7%
CATALENT INC -5.3%
JAZZ PHARMACEUTICALS PLC -4.5%
AXSOME THERAPEUTICS, INC. -4.4%
VIATRIS, INC. -4.3%
ORGANON & CO. -3.7%
PERRIGO CO -3.7%
ROYALTY PHARMA PLC CLASS A -3.7%
INTRA-CELLULAR THERAPIES INC -3.6%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY